Novo Owner’s CEO on Obesity Sales Boom, Catalent Deal

Поделиться
HTML-код
  • Опубликовано: 11 мар 2024
  • Novo Holdings CEO Kasim Kutay discusses the surge in income from obesity drug sales and offers an update on the Catalent deal and insight on the company’s deal strategy.

Комментарии • 2

  • @cerealpeer
    @cerealpeer 2 месяца назад

    and now for the real news

  • @cerealpeer
    @cerealpeer 2 месяца назад

    skull emoji
    skull
    emoji
    akull emoji
    akull
    skull emoji
    dan olivers restless grave
    skull emoji
    😮
    etc.